Sign In
Buy OVID
$2.44
-0.0100 (-0.408%)
At Close: Jul 17, 2026
Ovid Therapeutics Strengthens Board & Leadership Team to Focus Efforts on Expanding Its Neurosciences Capabilities
04:30pm, Thursday, 08'th Jul 2021
Dr. Michael Poole to Join the Board of Directors
Ovid Therapeutics: Good Entry Point For Investors
05:09pm, Friday, 18'th Jun 2021
There are promising results for OV-935 in patients with Dravet Syndrome, with questionable results in patients with Lennox-Gastaut Syndrome (LGS). Pipeline drug OV-935 shows high revenue potential.
3 Biotech Stocks to Keep an Eye On Amid the Coronavirus Mayhem
12:02pm, Thursday, 20'th May 2021
3 Biotech Stocks to Keep an Eye On Amid the Coronavirus Mayhem
Ovid Therapeutics to Participate in the 2021 RBC Capital Markets Global Healthcare Conference
08:00am, Wednesday, 12'th May 2021
NEW YORK, May 12, 2021 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurologica
HMNY Stock & 7 Other Reddit Penny Stocks Hoping for a Takeover
11:37am, Friday, 30'th Apr 2021
The odds of bankrupt HMNY stock getting acquired may be slim, but for these seven other Reddit penny stocks it's definitely a possibility. The post HMNY Stock & 7 Other Reddit Penny Stocks Hoping for
OVID Stock Price Increased Over 5% Pre-Market: Why It Happened
09:20am, Tuesday, 30'th Mar 2021
The stock price of Ovid Therapeutics Inc. (NASDAQ: OVID) increased by over 5% pre-market. This is why it happened.
8 Biotech Penny Stocks for Investors to Watch
11:54am, Wednesday, 10'th Mar 2021
Low-priced biotechs have sold off recently, but there could still be potential in these picks. Here are eight penny stocks to consider.
OVID Stock News: The Big Deal That Has Ovid Therapeutics Rocketing Higher Today
11:38am, Wednesday, 03'rd Mar 2021
Ovid Therapeutics (OVID) stock is soaring higher on Wednesday after announcing a massive deal with Takeda Pharmaceutical (TKPHF). The post OVID Stock News: The Big Deal That Has Ovid Therapeutics Rock
Why Ovid, KemPharm, Sorrento, Aquestive Are Rallying
10:17am, Wednesday, 03'rd Mar 2021
Ovid Therapeutics Inc. (NASDAQ: OVID), KemPharm Inc (NASDAQ: KMPH), Aquestive Therapeutics Inc (NASDAQ: AQST) and Sorrento Therapeutics, Inc. (NASDAQ: SRNE) were among the health care gainers in Wedne
Ovid Shares Rally On Soticlestat Development Pact With Takeda In Rare Epilepsy Syndromes
09:37am, Wednesday, 03'rd Mar 2021
Takeda Pharmaceutical Co Ltd (NYSSE: TAK) has agreed to secure global rights from Ovid Therapeutics Inc (NASDAQ: OVID) for soticlestat (TAK-935/OV935) for the treatment of developmental and epilep
OVID Stock Price Increases Over 60% Pre-Market: Why It Happened
07:33am, Wednesday, 03'rd Mar 2021
The stock price of Ovid Therapeutics Inc (NASDAQ: OVID) increased by over 60% pre-market. This is why it happened.
Ovid Therapeutics Announces Addition to the Nasdaq Biotechnology Index
07:00am, Wednesday, 16'th Dec 2020
NEW YORK, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurologi
Why Ovid Therapeutics Stock Is Imploding Today
11:38am, Wednesday, 02'nd Dec 2020
The company reported disappointing results from a late-stage clinical trial.
NEW YORK, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurologi
Ovid Therapeutics to Present at the American Epilepsy Society (AES) 2020 Virtual Congress
04:01pm, Monday, 23'rd Nov 2020
Abstracts will be presented from the TAK-935/OV935 (soticlestat) clinical development program in Dravet syndrome or Lennox-Gastaut syndrome (Phase 2 ELEKTRA study) and OV101 (gaboxadol) clinical devel
